Coffee Microcaps 4C Results Wrap with IMB & IMC

Описание: This webinar is proudly sponsored by RaaS Research. You can learn more about RaaS Research by visiting their website: https://www.raasgroup.com/

We had the following presenters for this Coffee Microcaps Morning Meeting.

0:00:00 - Introduction by Mark Tobin, Founder of Coffee Microcaps
0:03:33 - Dennison Hambling, MD of Intelligent Monitoring Group Ltd (ASX: IMB)
0:33:56 - Steven Lydeamore, CEO of Immuron Ltd (ASX: IMC)

About Intelligent Monitoring Group Ltd (ASX: IMB)
IMG is a leading provider of monitored security and IoT solutions, serving over 210,000 businesses, homes, and individuals in Australia and New Zealand through its subsidiary brands ADT, Signature Security Group, and Intelligent Monitoring Solutions.

Highest security accreditation from its four significant monitoring centres with operations out of all major cities in Australasia – Adelaide, Brisbane, Melbourne, Sydney, Canberra, Perth, Auckland, Wellington, Hamilton, and Christchurch, with a presence in many other locations.

To find out more about Intelligent Monitoring Group, please visit: https://intelligentmonitoringgroup.co...

About Immuron Limited (ASX: IMC, NASDAQ: IMRN)
Immuron is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. About Travelan® Travelan® is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting travellers’ diarrhoea, a digestive tract disorder that is commonly caused by pathogenic bacteria and the toxins they produce. Travelan® is a highly purified tabletized preparation of hyperimmune bovine antibodies and other factors, which, when taken with meals, bind to diarrhoea-causing bacteria and prevent colonisation and the pathology associated with travellers’ diarrhoea. In Australia, Travelan® is a listed medicine on the Australian Register for Therapeutic Goods (AUST L 106709) and is indicated to reduce the risk of travellers' diarrhoea, reduce the risk of minor gastrointestinal disorders, and is antimicrobial. In Canada, Travelan® is a licensed natural health product (NPN 80046016) and is indicated to reduce the risk of travellers’ diarrhoea. In the U.S., Travelan® is sold as a dietary supplement for digestive tract protection.

Travelers’ diarrhea (TD) TD is generally defined as the passage of ≥ 3 unformed stools per 24 hours plus at least one additional symptom (such as nausea, vomiting, abdominal cramps, fever, blood/mucus in the stools, or fecal urgency) that develop while abroad or within 10 days of returning from any resource-limited destinations (Leung et al., 2006). Diarrhoea continues to be the most frequent health problem among travellers to destinations in lower- and middle-income regions (Steffen, 2017). Deployed US military personnel, who essentially represent a long-term traveller population, are particularly affected due to their unique population dynamics and the context in which they seek care and treatment (Connor et al., 2012). Diarrhoea is the leading infectious disease threat to the overall health and preparedness of deployed US armed forces, with diarrheagenic E. coli, Campylobacter spp., and Shigella spp. among the most commonly reported etiologies (Riddle et al., 2006).

⏤ ⏤ ⏤ ⏤ ⏤ ⏤ ⏤ ⏤ ⏤ ⏤ ⏤ ⏤ ⏤ ⏤ ⏤ ⏤

Find out more about Coffee Microcaps.

Subscribe to Coffee Microcaps Newsletter https://coffeemicrocaps.substack.com./

Follow Coffee Microcaps on Twitter:   / cmicrocaps  

Follow Coffee Microcaps on LinkedIn:   / 4083  .

Get more from Coffee Microcaps Website: https://www.coffeemicrocaps.com/